01 3Entresto
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 3,548
2020 Revenue in Millions : 2,497
Growth (%) : 42
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 4,644
2021 Revenue in Millions : 3,548
Growth (%) : 31
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 6,035
2022 Revenue in Millions : 4,644
Growth (%) : 30
